Gencor Releases First Quarter Fiscal 2016 Results
Feb 10, 2016 14:56 pm UTC| Business
ORLANDO, Fla., Feb. 10, 2016 -- Gencor Industries, Inc. (Nasdaq:GENC) announced today net revenues increased 111% to $13.3 million for the quarter ended December 31, 2015 compared to $6.3 million for the quarter ended...
Massive Free Medical Clinic for Underserved Will Return to Dallas
Feb 10, 2016 14:51 pm UTC| Business
DALLAS, Feb. 10, 2016 -- A one-day, free health clinic will be held Saturday, April 9, in Dallas to provide much-needed care to people with limited or no access to health care. The clinic will be sponsored by the National...
Software Wars: What Approach is Right for You?
Feb 10, 2016 14:40 pm UTC| Business Technology
Cloud computing software has brought many changes to the business landscape and currently, the implementation of such a service is common. New research from Simon Business School at the University of Rochester sheds light...
Every Detail Matters as Papyrus Returns to New York Fashion Week
Feb 10, 2016 14:40 pm UTC| Business
CHICAGO, Feb. 10, 2016 -- Papyrus is excited to announce its return to New York Fashion Week: The Shows for the eighth consecutive season. As the official greeting card sponsor, Papyrus is once again elevating its...
Sale of FSRU Golar Tundra to Golar LNG Partners LP
Feb 10, 2016 14:36 pm UTC| Business
HAMILTON, Bermuda, Feb. 10, 2016 -- Golar LNG Limited ("Golar") announced today thatit has entered into a purchase agreement to sell the Golar Tundra, a floating storage and regasification unit, to Golar LNG Partners LP...
AFPM Reacts to U.S. Supreme Court's Decision to Hold EPA's Clean Power Plan
Feb 10, 2016 14:34 pm UTC| Business
WASHINGTON, Feb. 10, 2016 -- AFPM President Chet Thompson issued the following statement in response to the Supreme Court's decision on the Clean Power Plan: "The Court's rare move confirms the legal vulnerability of...
Stonegate Capital Partners Publishes Research Report on PharmaCyte Biotech
Feb 10, 2016 14:32 pm UTC| Business
SILVER SPRING, Md., Feb. 10, 2016 -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a clinical stage biotechnology company focused on developing targeted treatments for cancer and diabetes using its signature live-cell...